BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Genentech returns rights to IDEC-Y2B8 to IDEC
Oct. 6, 1997
IL-2 + IFN-alpha in phase II for renal cell carcinoma
Oct. 1, 1997
Techniclone submits IND for malignant glioma
Sep. 30, 1997
Ribi's melanoma vaccine accepted for fast-track review in Canada
Sep. 29, 1997
Betathine available for licensing from Dovetail
Sep. 29, 1997
Novopharm Biotech seeks approval for melanoma vaccine trial
Sep. 17, 1997
PDL grants antibody humanization patent license to NeoRx
Sep. 17, 1997
Biomira reports phase II results for cancer vaccine
Sep. 15, 1997
New clinical study on Multikine initiated in Canada
Sep. 12, 1997
Regressin induces apoptosis and direct inhibition of tumor cell growth
Sep. 12, 1997
Previous
1
2
…
976
977
978
979
980
981
982
983
984
…
994
995
Next